Diochot S, Schweitz H, Béress L, Lazdunski M
Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, 660 route des Lucioles, Sophia Antipolis, 06560 Valbonne, France.
J Biol Chem. 1998 Mar 20;273(12):6744-9. doi: 10.1074/jbc.273.12.6744.
Sea anemone venom is known to contain toxins that are active on voltage-sensitive Na+ channels, as well as on delayed rectifier K+ channels belonging to the Kv1 family. This report describes the properties of a new set of peptides from Anemonia sulcata that act as blockers of a specific member of the Kv3 potassium channel family. These toxins, blood depressing substance (BDS)-I and BDS-II, are 43 amino acids long and differ at only two positions. They share no sequence homologies with other K+ channel toxins from sea anemones, such as AsKS, AsKC, ShK, or BgK. In COS-transfected cells, the Kv3.4 current was inhibited in a reversible manner by BDS-I, with an IC50 value of 47 nM. This inhibition is specific because BDS-I failed to block other K+ channels in the Kv1, Kv2, Kv3, and Kv4 subfamilies. Inward rectifier K+ channels are also insensitive to BDS-I. BDS-I and BDS-II share the same binding site on brain synaptic membranes, with K0.5 values of 12 and 19 nM, respectively. We observed that BDS-I and BDS-II have some sequence homologies with other sea anemone Na+ channels toxins, such as AsI, AsII, and AxI. However, they had a weak effect on tetrodotoxin-sensitive Na+ channels in neuroblastoma cells and no effect on Na+ channels in cardiac and skeletal muscle cells. BDS-I and BDS-II are the first specific blockers identified so far for the rapidly inactivating Kv3.4 channel.
已知海葵毒液含有对电压敏感的Na⁺通道以及属于Kv1家族的延迟整流K⁺通道有活性的毒素。本报告描述了一组来自沟迎风海葵的新肽的特性,这些肽可作为Kv3钾通道家族特定成员的阻滞剂。这些毒素,即降血压物质(BDS)-I和BDS-II,长度为43个氨基酸,仅在两个位置不同。它们与来自海葵的其他K⁺通道毒素,如AsKS、AsKC、ShK或BgK,没有序列同源性。在COS转染细胞中,BDS-I以可逆方式抑制Kv3.4电流,IC50值为47 nM。这种抑制是特异性的,因为BDS-I未能阻断Kv1、Kv2、Kv3和Kv4亚家族中的其他K⁺通道。内向整流K⁺通道对BDS-I也不敏感。BDS-I和BDS-II在脑突触膜上具有相同的结合位点,K0.5值分别为12和19 nM。我们观察到BDS-I和BDS-II与其他海葵Na⁺通道毒素,如AsI、AsII和AxI,有一些序列同源性。然而,它们对神经母细胞瘤细胞中河豚毒素敏感的Na⁺通道作用较弱,对心肌和骨骼肌细胞中的Na⁺通道没有作用。BDS-I和BDS-II是迄今为止鉴定出的首个针对快速失活的Kv3.4通道的特异性阻滞剂。